RDZN Stock Risk & Deep Value Analysis

Roadzen Inc

DVR Score

7.1

out of 10

Solid Pick

What You Need to Know About RDZN Stock

We analyzed Roadzen Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran RDZN through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.

Updated May 16, 2026Run Fresh Analysis →

RDZN Risk Analysis & Red Flags

What Could Go Wrong

Roadzen is still an early-stage company burning cash, despite the recent capital raise. If new revenue streams from India, UK, and the U.S. do not materialize quickly or are insufficient to offset operational costs, the company may face further significant dilution, which could materially depress the stock price.

Risk Matrix

Overall

Aggressive

Financial

High

Market

Medium

Competitive

Medium

Execution

Medium

Regulatory

Low

Red Flags

  • Continued reliance on equity offerings for funding without a clear path to sustained free cash flow positivity.

  • Lack of comprehensive public financial data (margins, FCF) available through basic search, indicating high information asymmetry.

  • Absence of insider buying and reported institutional selling in late 2025 suggests cautious or negative sentiment from larger players.

Upcoming Risk Events

  • 📅

    Delay or failure in launching Anthropic-powered agents

  • 📅

    Slower-than-expected conversion of LOI to binding US capacity

  • 📅

    Failure to achieve profitability targets or requiring further significant dilution

When to Reconsider

  • 🚪

    Exit if the U.S. insurance capacity LOI is terminated or significantly reduced.

  • 🚪

    Sell if cash burn accelerates without a proportional increase in high-margin revenue.

  • 🚪

    Exit if Q4 2026 earnings (or subsequent reports) show revenue deceleration or a significant reversal in Adjusted EBITDA improvement.

Unlock RDZN Risk Analysis & Red Flags

Create a free account to see the full analysis

Investment Thesis

Roadzen is an early-stage insurtech poised for significant growth by leveraging AI, telematics, and computer vision to disrupt the global insurance industry. Recent strategic wins, including a collaboration with Anthropic, major new revenue contracts in India and the UK, and an LOI for U.S. market entry, validate its technology and execution. Despite current unprofitability and dilution, its expanding competitive moat and a clear path to substantially increased revenue streams position it for potential 10x growth within 3-5 years as it scales globally and moves towards profitability.

Is RDZN Stock Undervalued?

Roadzen Inc. is showing tangible progress in the high-potential insurtech sector, justifying an increased score. The recent $8M capital raise, while dilutive, provides critical funding, directly addressing previous concerns about financial runway. Strategic momentum is strong with a significant collaboration with Anthropic for AI insurance agents, a new $10M+ annual revenue mandate in India, $2.5M in UK contracts, and a major LOI for $30M-$50M annual underwriting capacity in the U.S. These developments solidify its competitive advantage in AI, demonstrate strong execution, and open up substantial new revenue streams, making the path to 10x growth more discernible. While profitability and cash flow remain areas of concern typical for growth-stage companies, the improving Adjusted EBITDA trend and robust pipeline mitigate some risk. The company's strategic positioning and execution on its vision for AI-driven insurance workflow are compelling.

Unlock the full AI analysis for RDZN

Get the complete DVR score, risk analysis, and more

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

RDZN Price Targets & Strategy

12-Month Target

$5.50

Bull Case

$8.00

Bear Case

$1.20

Valuation Basis

5x FY27E Revenue of $93.5M on 84.4M shares = $5.54/share.

Entry Strategy

Consider dollar-cost averaging on dips below $2.00, targeting strong support around $1.50 if it retests. Monitor the 50-day SMA for potential entry points.

Exit Strategy

Take partial profits at $4.00 and $6.50. Set a stop-loss order if the price consistently breaks below $1.40 (recent offering price/strong support).

Portfolio Allocation

7-10% for aggressive risk tolerance; 3-5% for moderate risk tolerance.

Price Targets & Strategy

Sign up free to unlock price targets and entry/exit strategies

Is RDZN Financially Healthy?

Valuation

P/E Ratio

-8.76

Forward P/E

1.00

Price/Book

-2.80

Price/Sales

1.90

Profitability

Gross Margin

60.93%

Operating Margin

-26.19%

Net Margin

-30.61%

Return on Equity

-20.26%

Revenue Growth

17.28%

EPS

$-0.20

Balance Sheet

Current Ratio

0.47

Quick Ratio

0.45

Debt/Equity

0.00

Cash Flow

Operating Cash Flow

-$20.00M

Free Cash Flow

-$21.00M

Other

Beta (Volatility)

1.19

Does RDZN Have a Competitive Moat?

Sign in to unlock

Moat Rating

🛡️ Narrow

Moat Trend

Expanding

Moat Sources

3 Identified

Intangible Assets/IP (patents in AI facial recognition, proprietary algorithms)Switching Costs (integrated AI solutions into insurer workflows, data lock-in)Network Effects (as more workshops and insurers join, data insights improve, attracting more users)

The moat is strengthening due to continued investment in AI technology, new patent grants, and high-profile partnerships like Anthropic. As their platform integrates deeper into insurer operations and collects more data, the switching costs for clients increase, and the predictive power of their AI improves, making their solutions more valuable and harder to replicate.

Moat Erosion Risks

  • Rapid advancements in general-purpose AI could diminish the uniqueness of their proprietary algorithms if not continuously updated.
  • Competitors developing similar deep integrations or acquiring smaller tech players to build comparable offerings.
  • Failure to scale operations could lead to customer dissatisfaction and reduced switching costs.

RDZN Competitive Moat Analysis

Sign up to see competitive advantages

RDZN Market Intelligence

Sentiment & Insider Activity

Social Sentiment

Neutral to cautiously Bullish. Retail investors are likely intrigued by the Anthropic collaboration and new contracts but wary of dilution.

Institutional Sentiment

Neutral. While the recent offering suggests some institutional interest, the prior period showed institutional selling, and current analyst coverage is sparse.

Insider Activity (Form 4)

No Form 4 insider transactions were identified in the last 90 days. The previous analysis noted an absence of recent insider buying and continued institutional selling in late 2025. This indicates a lack of strong positive conviction from insiders currently.

Options Flow

Normal options activity. No significant unusual put/call ratio or large block trades were identified in the provided research.

Earnings Intelligence

Next Earnings

Estimated late May / early June 2026 (for Q4 2026/FY2026 results)

Surprise Probability

Medium (given new contract announcements are positive, but overall financial health remains uncertain)

Historical Earnings Pattern

Limited public history post-de-SPAC. Prior analysis noted Q3 2026 revenue was up, with a sixth consecutive quarter of Adjusted EBITDA improvement. Market reaction to these earnings is not well-established, but positive operational news has typically been met with interest.

Key Metrics to Watch

YoY and sequential revenue growth (looking for acceleration beyond 18.78%)Update on Adjusted EBITDA trend and progress towards net profitabilityGuidance on impact of new VehicleCare India, UK GIM, and US LOI revenue streams

Competitive Position

Top Competitor

Lemonade (LMND) or Root (ROOT) for tech-forward insurance, or a pure insurtech SaaS platform like Guidewire (GWRE) for enterprise software to insurers.

Market Share Trend

Gaining. Recent major contract wins in India, the UK, and the strategic LOI for US capacity indicate significant inroads into new markets and customer segments.

Valuation vs Peers

Roadzen currently trades at a significant discount to established insurtech SaaS providers like Guidewire on a P/S basis, reflecting its earlier stage, unprofitability, and smaller scale. Its ~2.4x annualized P/S is lower than many high-growth SaaS companies, offering potential for multiple expansion if it executes on its growth strategy and moves towards profitability. Compared to direct insurers using tech (LMND, ROOT), its business model is more B2B SaaS, implying higher potential multiples upon reaching scale.

Competitive Advantages

  • Proprietary AI/ML and computer vision technology focused on insurance workflows (underwriting, claims).
  • Strategic partnerships with leading AI firms (Anthropic) enhancing technological moat.
  • Global reach with established operations in India and UK, and now targeting the substantial US market.

Market Intelligence

Sign up free to unlock sentiment, earnings intel, and peer analysis

What Could Drive RDZN Stock Higher?

Near-Term (0-6 months)

  • Q4 2026 Earnings Report (estimated late May/early June 2026)
  • Official launch of Anthropic-powered AI insurance agents (Q2 2026)
  • Conversion of U.S. insurance capacity LOI into definitive agreement (Q2/Q3 2026)

Medium-Term (6-18 months)

  • Full revenue realization from VehicleCare India and UK GIM contracts (mid-2027)
  • Expansion of U.S. underwriting capacity and market penetration (mid-2027)
  • New strategic partnerships in key geographic markets (2027)

Long-Term (18+ months)

  • Achieving market leadership in AI-driven insurance platforms globally (2028-2029)
  • Disruption of traditional insurance underwriting and claims processes via AI automation
  • Significant IP licensing opportunities for core AI technologies

Catalysts & Growth Drivers

Sign up free to see growth catalysts

What's the Bull Case for RDZN?

  • Acceleration in year-over-year revenue growth beyond current rates.

  • Positive free cash flow generation or a clearly articulated timeline to achieving it.

  • Expansion of gross and operating margins, indicating improved unit economics.

Bull Case Analysis

Sign up free to see the bull case

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

How Roadzen Inc Makes Money

Roadzen Inc. operates as a business-to-business (B2B) insurtech provider, offering an AI-powered platform to insurance companies globally. They help insurers automate and optimize core operations such as underwriting, claims processing, and customer engagement through the use of telematics, computer vision, and advanced artificial intelligence. By integrating their technology, Roadzen aims to reduce loss costs for insurers, improve efficiency, and enhance the customer experience, thereby generating revenue through platform fees, service contracts, and potentially licensing arrangements for their proprietary technology.

Read Full Business Model Breakdown

FAQ

What is the DVR Score for Roadzen Inc (RDZN)?

As of May 16, 2026, Roadzen Inc has a DVR Score of 7.1 out of 10, placing it in the "Solid Pick" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Roadzen Inc?

Roadzen Inc's market capitalization is approximately $147.4M..

What is the risk level for RDZN stock?

Our analysis rates Roadzen Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of RDZN?

Roadzen Inc currently has a price-to-earnings (P/E) ratio of -8.8. This is below the market average, which could indicate the stock is undervalued or facing headwinds.

Is Roadzen Inc's revenue growing?

Roadzen Inc has reported revenue growth of 17.3%. The company is showing strong top-line momentum.

Is RDZN stock profitable?

Roadzen Inc has a profit margin of -30.6%. The company is currently unprofitable.

How often is the RDZN DVR analysis updated?

Our AI-powered analysis of Roadzen Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on May 16, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for RDZN (Roadzen Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

Navigated to RDZN Stock Risk & Deep Value Analysis